{
    "Trade/Device Name(s)": [
        "Stratus\u00ae CS Acute CareTM BhCG TestPak",
        "Stratus\u00ae CS Acute CareTM BhCG CalPak",
        "Stratus\u00ae CS Acute CareTM BhCG DilPak",
        "Stratus\u00ae CS Acute CareTM NT-proBNP (pBNP) TestPak",
        "Stratus\u00ae CS Acute CareTM NT-proBNP (pBNP) CalPak",
        "Stratus\u00ae CS Acute CareTM NT-proBNP (pBNP) DilPak"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K060548",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003696",
        "K043476"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA",
        "NBC",
        "JIT"
    ],
    "Summary Letter Date": "April 6, 2006",
    "Summary Letter Received Date": "March 1, 2006",
    "Submission Date": "February 28, 2006",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac",
        "POCT"
    ],
    "Analyte(s)": [
        "Beta subunit of human chorionic gonadotropin (\u03b2hCG)",
        "N-terminal pro-brain natriuretic peptide (NT-proBNP)"
    ],
    "Specimen Type(s)": [
        "Heparinized plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Stratus\u00ae CS analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Solid phase two-site sandwich fluorometric immunoassay",
        "Radial Partition Immunoassay (RPIA)"
    ],
    "Methodologies": [
        "Fluorometric immunoassay",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "TestPak",
        "CalPak",
        "DilPak",
        "Assay",
        "Calibrator",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for Dade Behring Stratus CS Acute Care BhCG and NT-proBNP TestPak, CalPak, and DilPak for quantitative measurement in heparinized plasma using immunoassay technology",
    "Indications for Use Summary": "Quantitative measurement of total \u03b2hCG in heparinized plasma for early detection of pregnancy and NT-proBNP for diagnosis, severity assessment, and risk stratification in heart failure and acute coronary syndrome, for clinical laboratory and point-of-care use",
    "fda_folder": "Clinical Chemistry"
}